DNA assisting CRISPR-Cas13a activation regulating assay for detection of DNA mutation and miRNAs
Biosensors and Bioelectronics · 2027-01 · 316 · 119344
DOI: 10.1016/j.bios.2026.119344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2027-01. Verfasst von Changqing Wan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 4…. Hauptthemen laut MEDLINE: MicroRNAs, Biosensing Techniques, CRISPR-Cas Systems, DNA. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Cas13a is an RNA-targeting effector system with exceptional sensitivity, essential for applications such as mutation discrimination, RNA biomarker quantification and dynamic monitoring. However, precise control over its activation kinetics and thermodynamics remains a fundamental challenge, limiting its use in nucleic acid detection. Here, we present the DNA-Assisting CRISPR-Cas13a Activation Regulating (DACAR) Assay, which employs a single-stranded DNA blocker to occupy the crRNA spacer. Through programmable toehold-mediated strand displacement (TMSD) and toehold-exchange (TE) reactions, DACAR is able to control the thermodynamics and kinetics of Cas13a activation at two different levels. Systematic modulation of toehold length and direction yields a tunable cleavage rate gradient, while TE-based free-energy tuning facilitates an ON/OFF gating mode. For single-nucleotide variant (SNV) discrimination, DACAR-TE amplifies thermodynamic mismatch effects, achieving a discrimination factor of 162.4 and a detection limit of 0.05% mutant abundance for the KRAS G12D mutation. The Switch-DACAR system also enables sequential detection of miR-155 and miR-21 in a single tube, with a detection limit of 10 pM. To sum up, DACAR provides a unified, programmable framework for precise molecular-level control of Cas13a, advancing its potential in diagnostics and molecular logic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
- GI Cancer Research Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: pcli1999@hust.edu.cn.
- Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. Electronic address: 1625712361@tjh.tjmu.edu.cn.
- Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. Electronic address: liaoyw@tjh.tjmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wan, C., Liu, W., Pan, S., Wang, X., Zhou, J., Hu, Y., Li, P., Nie, X., & Liao, Y. (2027). DNA assisting CRISPR-Cas13a activation regulating assay for detection of DNA mutation and miRNAs. Biosensors and Bioelectronics, 316, 119344. https://doi.org/10.1016/j.bios.2026.119344
Vancouver
Wan C, Liu W, Pan S, Wang X, Zhou J, Hu Y, et al. DNA assisting CRISPR-Cas13a activation regulating assay for detection of DNA mutation and miRNAs. Biosensors and Bioelectronics. 2027;316:119344. doi:10.1016/j.bios.2026.119344
BibTeX
@article{Wan2027,
author = {Wan, Changqing and Liu, Wenzheng and Pan, Shutao and Wang, Xiaoxiang and Zhou, Jingcong and Hu, Yibo and Li, Pengcheng and Nie, Xiaoqi and Liao, Yangwei},
title = {DNA assisting CRISPR-Cas13a activation regulating assay for detection of DNA mutation and miRNAs},
journal = {Biosensors and Bioelectronics},
year = {2027},
volume = {316},
pages = {119344},
doi = {10.1016/j.bios.2026.119344}
}
EUVIMED